Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Warren

Showing results (61-70 of 256) with videos related to

Pageof 26
Sort By:
Dermatology and Therapy|December 22, 2020
Assessing the Quality and Coherence of Network Meta-Analyses of Biologics in Plaque Psoriasis: What Does All This Evidence Synthesis Tell Us?Emily Wright, Najeeda Yasmeen, Kinga Malottki, et al.
Skin Health and Disease|June 7, 2024
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panelJonathan N Barker, Gabrielle Becher, David A Burden, et al.
Dermatology and Therapy|August 2, 2021
Long-Term Proactive Treatment of Plaque Psoriasis with Calcipotriene/Betamethasone Dipropionate Foam Prolongs Remission and Reduces Relapses Irrespective of Patient Baseline CharacteristicsMark G Lebwohl, Kim A Papp, Marie Holst Mørch, et al.
Experimental Dermatology|September 19, 2025
Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque PsoriasisRichard B Warren, Anne Weiss, Jakob Felding, et al.
JAMA Dermatology|May 31, 2023
Biosimilars for the Treatment of Psoriasis: A Systematic Review of Clinical Trials and Observational StudiesDuc Binh Phan, Sarah Elyoussfi, Michael Stevenson, et al.
The British Journal of Dermatology|March 8, 2024
The use of serum methotrexate level as an assessment of biochemical drug adherence in psoriasisAmelle G Ra, Zoe Littlewood, Anne Barton, et al.
The Journal of Investigative Dermatology|June 27, 2008
No association between polymorphisms in the interleukin-15 gene and early-onset psoriasis in a UK cohort suggests heterogeneity for this susceptibility locus identified in Chinese psoriasis patientsRhodri Ll Smith, Steve Eyre, Richard B Warren, et al.
Dermatology and Therapy|December 6, 2025
Lebrikizumab for the Treatment of Moderate to Severe Atopic Eczema: Real-World Experience from a Tertiary CentreAzmeralda Abraheem, Neenu Sebastian, Firas C Kreeshan, et al.
Dermatology and Therapy|May 29, 2025
Real-World Clinical Experience of Tralokinumab in a Tertiary Centre: An Alternative for Patients with Conjunctivitis on Dupilumab?Neenu Sebastian, Omar Chircop, Tim H Clayton, et al.
Dermatology and Therapy|November 6, 2019
Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analysesRichard B Warren, Kyoungah See, Russel Burge, et al.
Pageof 26

Showing results (61-70 of 256) with videos related to

Sort By:
Pageof 26
Dermatology and Therapy|December 22, 2020
Assessing the Quality and Coherence of Network Meta-Analyses of Biologics in Plaque Psoriasis: What Does All This Evidence Synthesis Tell Us?Emily Wright, Najeeda Yasmeen, Kinga Malottki, et al.
Skin Health and Disease|June 7, 2024
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panelJonathan N Barker, Gabrielle Becher, David A Burden, et al.
Dermatology and Therapy|August 2, 2021
Long-Term Proactive Treatment of Plaque Psoriasis with Calcipotriene/Betamethasone Dipropionate Foam Prolongs Remission and Reduces Relapses Irrespective of Patient Baseline CharacteristicsMark G Lebwohl, Kim A Papp, Marie Holst Mørch, et al.
Experimental Dermatology|September 19, 2025
Orismilast, a Potent and Selective PDE4B/D Inhibitor, Reduces Protein Levels of Key Disease Driving Cytokines in the Skin of Patients With Plaque PsoriasisRichard B Warren, Anne Weiss, Jakob Felding, et al.
JAMA Dermatology|May 31, 2023
Biosimilars for the Treatment of Psoriasis: A Systematic Review of Clinical Trials and Observational StudiesDuc Binh Phan, Sarah Elyoussfi, Michael Stevenson, et al.
The British Journal of Dermatology|March 8, 2024
The use of serum methotrexate level as an assessment of biochemical drug adherence in psoriasisAmelle G Ra, Zoe Littlewood, Anne Barton, et al.
The Journal of Investigative Dermatology|June 27, 2008
No association between polymorphisms in the interleukin-15 gene and early-onset psoriasis in a UK cohort suggests heterogeneity for this susceptibility locus identified in Chinese psoriasis patientsRhodri Ll Smith, Steve Eyre, Richard B Warren, et al.
Dermatology and Therapy|December 6, 2025
Lebrikizumab for the Treatment of Moderate to Severe Atopic Eczema: Real-World Experience from a Tertiary CentreAzmeralda Abraheem, Neenu Sebastian, Firas C Kreeshan, et al.
Dermatology and Therapy|May 29, 2025
Real-World Clinical Experience of Tralokinumab in a Tertiary Centre: An Alternative for Patients with Conjunctivitis on Dupilumab?Neenu Sebastian, Omar Chircop, Tim H Clayton, et al.
Dermatology and Therapy|November 6, 2019
Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analysesRichard B Warren, Kyoungah See, Russel Burge, et al.
Pageof 26